[1. International Diabetes Federation. IDF Diabetes, 8 ed. Brussels, Belgium. International Diabetes Federation, 2017. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas.html. Accesed on 04th of February 2018.]Search in Google Scholar
[2. WHO. 10 facts on diabetes. April 2016. http://www.who.int/features/factfiles/diabetes/en/ Accessed on 28th of December 2016.]Search in Google Scholar
[3. American Diabetes Association. Standards of Medical Care. Diabetes Care. 2016;39 (Suppl 1): S1-112.]Search in Google Scholar
[4. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c independent risk factor for diabetic complications. J Am Med Assoc. 2006;295(14):1707–8. DOI: 10.1001/jama.295.14.170710.1001/jama.295.14.1707]Search in Google Scholar
[5. Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF et al. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014;6(1):139. DOI: 10.1186/1758-5996-6-13910.1186/1758-5996-6-139]Open DOISearch in Google Scholar
[6. Smith-Palmer J, Brändle M, Trevisan R, Orsini Federici M, Liabat S, Valentine W. Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(3):273-84. DOI: 10.1016/j.diabres.2014.06.00710.1016/j.diabres.2014.06.007]Open DOISearch in Google Scholar
[7. Muggeo M, Verlato G, Bonora E, Zoppini G, Corbellini M, de Marco R. Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study. Circulation. 1997;96(6):1750–4. DOI: 10.1161/01.CIR.96.6.175010.1161/01.CIR.96.6.1750]Open DOISearch in Google Scholar
[8. Monnier L, Colette C, Owens DR. Glycemic Variability: The Third Component of the Dysglycemia in Diabetes. Is It Important? How to Measure It? J Diabetes Sci Technol. 2008 Nov;2(6):1094–100. DOI: 10.1177/19322968080020061810.1177/193229680800200618]Search in Google Scholar
[9. American Diabetes Association. Standards of Medical Care for Patients With Diabetes Mellitus. Diabetes Care 2002; 25(suppl 1): s33-s49. DOI: 10.2337/diacare.25.2007.S3310.2337/diacare.25.2007.S33]Open DOISearch in Google Scholar
[10. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53. DOI: 10.1016/S0140-6736(98)07019-610.1016/S0140-6736(98)07019-6]Search in Google Scholar
[11. Czerwoniuk D, Fendler W, Walenciak L, Mlynarski W. GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data. J Diabetes Sci Technol. 2011;5(2):447–51. DOI: 10.1177/19322968110050023610.1177/193229681100500236312594121527118]Open DOISearch in Google Scholar
[12. Khadilkar KS, Bandgar T, Shivane V, Lila A, Shah N. Current concepts in blood glucose monitoring. Indian J Endocrinol Metab.2013;17(Suppl 3): S643–9. DOI: 10.4103/2230-8210.12355610.4103/2230-8210.123556404659224910827]Open DOISearch in Google Scholar
[13. Ramchandani N. Continuous Glucose Monitoring. Troubleshooting Common Problems. Published May 3, 2012. http://www.diabetesselfmanagement.com/managing-diabetes/blood-glucose-management/continuous-glucose-monitoring/ Accessed on 14th of December 2017.]Search in Google Scholar
[14. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2006;29(7):1486–1490. DOI: 10.2337/dc06-029310.2337/dc06-029316801566]Open DOISearch in Google Scholar
[15. DeVries JH. Glucose variability: where it is important and how to measure it. Diabetes. 2013;62(5):1405–8. DOI: 10.2337/db12-161010.2337/db12-1610363664323613566]Search in Google Scholar
[16. Wójcicki JM. Mathematical descriptions of the glucose control in diabetes therapy. Analysis of the Schlichtkrull “M”-value. Horm Metab Res. 1995;27(1):1–5. DOI: 10.1055/s-2007-97989510.1055/s-2007-9798957729784]Open DOISearch in Google Scholar
[17. Wójcicki JM. “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res. 1995;27(1):41–2. DOI: 10.1055/s-2007-97990610.1055/s-2007-9799067729793]Open DOISearch in Google Scholar
[18. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644–55. DOI: 10.2337/diab.19.9.64410.2337/diab.19.9.6445469118]Open DOISearch in Google Scholar
[19. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ. A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther. 2005;7(2):253–63. DOI: 10.1089/dia.2005.7.25310.1089/dia.2005.7.25315857227]Open DOISearch in Google Scholar
[20. Inbody 720 User’s Manual. 1996-2004 Biospace Co, Ltd.; Available at: http://www.bodyanalyse.no/docs/720%20users%20manual.pdf.]Search in Google Scholar
[21. Jellinger P, Davidson J, Blonde L, Einhorn D, Grunberger G, Handelsman Y et al. Road Maps to Achieve Glycemic Control in Type 2 Diabetes Mellitus: ACE/AACE Diabetes Road Map Task Force. Endocrine Practice. 2007;13(3):260-8. DOI: 10.4158/EP.13.3.26010.4158/EP.13.3.26017599857]Search in Google Scholar
[22. American Diabetes Association. Standards of Medical Care. Diabetes Care. 2017;40(Suppl 1):S64-74.10.2337/dc17-S01127979895]Search in Google Scholar
[23. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycemia in Type 2 diabetes. Diabet Med. 2008;25(3):245–54. DOI: 10.1111/j.1464-5491.2007.02341.x10.1111/j.1464-5491.2007.02341.x232722118215172]Open DOISearch in Google Scholar
[24. Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and Cardiovascular Risk: Is There a Major Link? Diabetes Care. 2016;39(Suppl.2):S205-9. DOI: 10.2337/dcS15-301410.2337/dcS15-301427440834]Open DOISearch in Google Scholar
[25. Takeishi S, Mori A, Hachiya H, Yumura T, Ito S, Shibuya T et al. Hypoglycemia and glycemic variability are associated with mortality in non-intensive care unit hospitalized infectious disease patients with diabetes mellitus. J Diabetes Investig 2016;7(3):429–35. DOI: 10.1111/jdi.1243610.1111/jdi.12436484789927330731]Open DOISearch in Google Scholar
[26. Tricco AC, Ashoor HM, Soobiah C, Hemmelgarn B, Moher D, Hutton B et al. Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: protocol for a systematic review and network meta-analysis. Syst Rev 2013;2:73. DOI: 10.1186/2046-4053-2-7310.1186/2046-4053-2-73384712724020869]Open DOISearch in Google Scholar
[27. Bajaj HS, Venn K, Ye C, Patrick A, Kalra S, Khandwala H et al. Lowest Glucose Variability and Hypoglycemia Are Observed With the Combination of a GLP-1 Receptor Agonist and Basal Insulin (VARIATION Study). Diabetes Care. 2017;40(2):194-200. DOI: 10.2337/dc16-158210.2337/dc16-158227913575]Open DOISearch in Google Scholar
[28. Suh S, Kim JH. Glycemic Variability: How Do We Measure It and Why Is It Important? Diabetes Metab J. 2015;39(4):273–82. DOI: 10.4093/dmj.2015.39.4.27310.4093/dmj.2015.39.4.273454319026301188]Open DOISearch in Google Scholar
[29. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–7. DOI: 10.1001/jama.295.14.168110.1001/jama.295.14.168116609090]Open DOISearch in Google Scholar
[30. The FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016 Jun;39(6):973-81. DOI: 10.2337/dc15-278210.2337/dc15-278227208320]Open DOISearch in Google Scholar
[31. Kovatchev B, Cobelli C. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care. 2016; 39(4): 502-10. DOI: 10.2337/dc15-203510.2337/dc15-2035480677427208366]Search in Google Scholar
[32. Fabris C, Facchinetti A, Fico G, Sambo F, Arredondo MT, Cobelli C; MOSAIC EU Project Consortium. Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis. J Diabetes Sci Technol. 2015;10(1):119-24. DOI: 10.1177/193229681559617310.1177/1932296815596173473820826232371]Open DOISearch in Google Scholar
[33. Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N et al. Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care. 2017;40(7):832-8. DOI: 10.2337/dc16-176910.2337/dc16-176928039172]Open DOISearch in Google Scholar